date:Jun 22, 2012
d the consequences it could have for the future work of the agency.
This is important for considering whether or not EFSA needs to look at the low-dose hypothesis in more detail. It could have an important impact on EFSAs work in several areas,added the panel chief.
However, Alexandre Feigenbaum, who co-chaired the event, stressed that while forum had been useful, no firm conclusions had been reached.
There are still many uncertainties surrounding this debate but we have moved the discussion